SOURCE: Reliv International, Inc.

Reliv International: The Nutritional Epigenetics Company

October 02, 2015 07:00 ET

Reliv International Announces New Banking Relationship

CHESTERFIELD, MO--(Marketwired - October 02, 2015) - Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that it had entered into a new banking relationship with Enterprise Bank and Trust, based in St. Louis, Missouri.

On September 30, 2015, Reliv International, Inc. and three of its wholly-owned subsidiaries, Reliv, Inc., Reliv World Corporation and SL Technology, Inc. entered into a term loan with Enterprise Bank & Trust in the principal amount of $3.25 million. The term of the loan is for a period of three years with interest accruing on the outstanding principal balance at a floating interest rate based on the 30-day LIBOR plus 2.25%. The current interest rate is 2.451%. Monthly principal payments of $27,080 are based on a ten-year amortization. The aggregate outstanding balance of principal and interest is due and payable on September 30, 2018.

The Company and its subsidiaries also entered into a revolving credit facility for $3.5 million with the bank. The credit facility accrues interest on the outstanding principal balance at a floating interest rate based on 30-day LIBOR plus 2.25% and has a maturity date of September 30, 2016. As of this date, there are no outstanding borrowings on the revolving credit facility.

"We are pleased to begin a banking relationship with Enterprise and look forward to a long partnership with them," said Robert L. Montgomery, Chairman and Chief Executive Officer. "This credit facility, coupled with our current cash reserves, gives us the capital needed for our strategic initiatives to grow Reliv in the coming years," he added. As of June 30, 2015, Reliv had cash and cash equivalents of $4.50 million.

The proceeds of the term loan were used by the Company to pay off the outstanding balance of principal and accrued interest under its prior term loan and revolving credit facility with BMO Harris Bank N.A.

The terms of the term loan and revolving credit facility are reflected in separate promissory notes dated September 30, 2015. In addition, pursuant to a business loan agreement dated September 30, 2015, Reliv agreed to financial covenants under which the Registrant will maintain at all times a tangible net worth of not less than $9.5 million. The term loan and revolving credit facility are secured by all tangible and intangible assets of the Company, a whole life insurance policy on the life of the Company's Chief Executive Officer and also by a mortgage on the Company's building and real estate located in Chesterfield, Missouri.

About Reliv International, Inc.

Reliv International, based in Chesterfield, MO, produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy's health benefits. The company sells its products through an international network marketing system of independent distributors in 15 countries. Learn more about Reliv at www.reliv.com, or on Facebook, Twitter or YouTube.

Statements made in this news release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv's business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company's web site, www.reliv.com.

Contact Information

  • Steve Albright
    Chief Financial Officer
    (636) 733-1305